Turner Liam D, Zarkovic Andrea, Lee Siew Hua Jessica, Chan Weng, Ogra Siddharth, Brettell Daniel, Ohana Oded, Gounder Pavindran, Hayes Mark, Madge Simon
Department of Ophthalmology Hereford County Hospital Hereford UK.
Skin Health Dis. 2022 May 18;3(2):e123. doi: 10.1002/ski2.123. eCollection 2023 Apr.
Basal cell carcinoma (BCC) is one of the most common malignancies in the world. The frequency of histopathological subtypes and the distribution on the body of BCC has been well documented. Less has been written on the nature of secondary tumours. The genetics of BCC is starting to be understood, particularly with the advent of newer medical treatments (hedgehog inhibitors).
To determine if primary basal cell carcinoma histopathological subtype predicts secondary tumour subtype, as well as their anatomical distribution.
A retrospective case series of patients over the age of 18 was performed from 2009 to 2014, with at least two separate diagnoses of BCC.
In 394 identified patients, a total of 1355 BCCs arose in the cohort over the 6-year study period. The number of secondary BCCs per patient ranged from 2 to 19 tumours. Nodular BCC was the most likely to reoccur in secondary tumours (53.3%), followed by mixed subtypes (45.7%).
Within our study, we did find a predisposition for secondary BCCs to be of the same histopathological subtype as the primary, particularly with respect to nodular and mixed tumours. Furthermore, we found that secondary tumours were also more likely to occur on the same anatomical site as the primary tumour. We are only just beginning to under the genetic mutations involved in subtype formation.
基底细胞癌(BCC)是世界上最常见的恶性肿瘤之一。BCC组织病理学亚型的频率及其在身体上的分布已有充分记录。关于继发性肿瘤的性质的报道较少。随着更新的医学治疗方法(刺猬抑制剂)的出现,BCC的遗传学开始被人们所了解。
确定原发性基底细胞癌组织病理学亚型是否能预测继发性肿瘤亚型及其解剖分布。
对2009年至2014年18岁以上的患者进行回顾性病例系列研究,这些患者至少有两次独立的BCC诊断。
在394例确诊患者中,在6年的研究期间,队列中总共出现了1355例BCC。每位患者继发性BCC的数量从2个到19个不等。结节性BCC最有可能在继发性肿瘤中复发(53.3%),其次是混合亚型(45.7%)。
在我们的研究中,我们确实发现继发性BCC倾向于与原发性BCC具有相同的组织病理学亚型,特别是在结节性和混合性肿瘤方面。此外,我们发现继发性肿瘤也更有可能发生在与原发性肿瘤相同的解剖部位。我们才刚刚开始了解参与亚型形成的基因突变。